1. Home
  2. NXL vs CKX Comparison

NXL vs CKX Comparison

Compare NXL & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • CKX
  • Stock Information
  • Founded
  • NXL 2010
  • CKX 1930
  • Country
  • NXL United States
  • CKX United States
  • Employees
  • NXL N/A
  • CKX N/A
  • Industry
  • NXL Medical Specialities
  • CKX Oil & Gas Production
  • Sector
  • NXL Health Care
  • CKX Energy
  • Exchange
  • NXL Nasdaq
  • CKX Nasdaq
  • Market Cap
  • NXL 25.1M
  • CKX 22.6M
  • IPO Year
  • NXL 2022
  • CKX 1998
  • Fundamental
  • Price
  • NXL $1.24
  • CKX $10.60
  • Analyst Decision
  • NXL Strong Buy
  • CKX
  • Analyst Count
  • NXL 1
  • CKX 0
  • Target Price
  • NXL $5.00
  • CKX N/A
  • AVG Volume (30 Days)
  • NXL 675.7K
  • CKX 1.0K
  • Earning Date
  • NXL 11-07-2025
  • CKX 11-22-2025
  • Dividend Yield
  • NXL N/A
  • CKX N/A
  • EPS Growth
  • NXL N/A
  • CKX N/A
  • EPS
  • NXL N/A
  • CKX 0.18
  • Revenue
  • NXL $174,813.00
  • CKX $835,960.00
  • Revenue This Year
  • NXL $38.28
  • CKX N/A
  • Revenue Next Year
  • NXL $185.71
  • CKX N/A
  • P/E Ratio
  • NXL N/A
  • CKX $58.81
  • Revenue Growth
  • NXL 16.42
  • CKX N/A
  • 52 Week Low
  • NXL $0.70
  • CKX $10.02
  • 52 Week High
  • NXL $4.49
  • CKX $14.00
  • Technical
  • Relative Strength Index (RSI)
  • NXL 44.47
  • CKX 39.27
  • Support Level
  • NXL $1.44
  • CKX $10.02
  • Resistance Level
  • NXL $1.45
  • CKX $10.93
  • Average True Range (ATR)
  • NXL 0.13
  • CKX 0.18
  • MACD
  • NXL -0.05
  • CKX 0.01
  • Stochastic Oscillator
  • NXL 4.12
  • CKX 59.96

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

Share on Social Networks: